Charles River Laboratories Intl (($CRL)) has held its Q3 earnings call. Read on for the main highlights of the call. The ...

Innoviva (INVA) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.02 per share a year ago. These figures are ...

Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...

A regenerative medicine company will open a headquarters office in Boca that includes manufacturing and distribution ...

CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...

China's Angel Yeast has begun operating an 11,000-tonne production line for its yeast protein, bolstering the country's ...

A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year.

Alabama Governor Kay Ivey has awarded HudsonAlpha Institute for Biotechnology over $2 million for research supporting the agriculture and forestry industries. The funding for three initiatives comes ...

Sarepta nevertheless plans to push for full FDA approval of Vyondys 53 and Amondys 45 based on what it said are “encouraging ...